Trial Profile
Safety and Efficacy of Low-dose Prostacyclin Administration and Blood Pressure Target in Addition to Standard Therapy, as Compared to Standard Therapy Alone, in Post-cardiac-arrest-syndrome Patients - a Randomized, Controlled, Double-blinded Investigator-initiated Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Heart arrest
- Focus Pharmacodynamics
- Acronyms ENDO-RCA
- 21 Jun 2017 Status changed from recruiting to completed.
- 13 Jan 2015 New trial record